CD8A and neoplasm: Although all these aspects in CXCR5+PD‐1+ CD8 T cells themselves could play a role, the low levels of tumor neo‐antigens combined with the poor antigen presentation by CLL cells could also play a role for the low response rates to PD‐1 ICB [30, 31].